HORÁK, Tomáš, Magda HORÁKOVÁ, Alena SVÁTKOVÁ, Zdeněk KADAŇKA, Petr KUDLIČKA, Jan VALOSEK, Tomáš ROHAN, Miloš KEŘKOVSKÝ, Eva VLČKOVÁ, Zdeněk KADAŇKA, Dinesh K. DEELCHAND, Pierre-Gilles HENRY, Josef BEDNAŘÍK and Petr BEDNAŘÍK. In vivo Molecular Signatures of Cervical Spinal Cord Pathology in Degenerative Compression. Journal of Neurotrauma. New Rochelle: Mary Ann Liebert, vol. 38, No 21, p. 2999-3010. ISSN 0897-7151. doi:10.1089/neu.2021.0151. 2021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name In vivo Molecular Signatures of Cervical Spinal Cord Pathology in Degenerative Compression
Authors HORÁK, Tomáš (203 Czech Republic, belonging to the institution), Magda HORÁKOVÁ (203 Czech Republic, belonging to the institution), Alena SVÁTKOVÁ (703 Slovakia), Zdeněk KADAŇKA (203 Czech Republic, belonging to the institution), Petr KUDLIČKA (203 Czech Republic, belonging to the institution), Jan VALOSEK (203 Czech Republic), Tomáš ROHAN (203 Czech Republic), Miloš KEŘKOVSKÝ (203 Czech Republic), Eva VLČKOVÁ (203 Czech Republic, belonging to the institution), Zdeněk KADAŇKA (203 Czech Republic), Dinesh K. DEELCHAND, Pierre-Gilles HENRY, Josef BEDNAŘÍK (203 Czech Republic, belonging to the institution) and Petr BEDNAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition Journal of Neurotrauma, New Rochelle, Mary Ann Liebert, 2021, 0897-7151.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.869
RIV identification code RIV/00216224:14110/21:00120166
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1089/neu.2021.0151
UT WoS 000745030000006
Keywords in English cervical spinal cord; compression; degenerative magnetic resonance; myelopathy; spectroscopy
Tags 14110127, 14110221, CF MAFIL, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/2/2022 08:06.
Abstract
Degenerative cervical myelopathy (DCM) is a severe consequence of degenerative cervical spinal cord (CSC) compression. The non-myelopathic stage of compression (NMDC) is highly prevalent and often progresses to disabling DCM. This study aims to disclose markers of progressive neurochemical alterations in NMDC and DCM by utilizing an approach based on state-of-the-art proton magnetic resonance spectroscopy (1H-MRS). Proton-MRS data were prospectively acquired from 73 participants with CSC compression and 47 healthy controls (HCs). The MRS voxel was centered at the C2 level. Compression-affected participants were clinically categorized as NMDC and DCM, radiologically as mild (MC) or severe (SC) compression. CSC volumes and neurochemical concentrations were compared between cohorts (HC vs. NMDC vs. DCM and HC vs. MC vs. SC) with general linear models adjusted for age and height (pFWE < 0.05) and correlated to stenosis severity, electrophysiology, and myelopathy symptoms (p < 0.05). Whereas the ratio of total creatine (tCr) to total N-acetylaspartate (tNAA) increased in NMDC (+11%) and in DCM (+26%) and SC (+21%), myo-inositol/tNAA, glutamate + glutamine/tNAA, and volumes changed only in DCM (+20%, +73%, and −14%) and SC (+12%, +46%, and −8%, respectively) relative to HCs. Both tCr/tNAA and myo-inositol/tNAA correlated with compression severity and volume (−0.376 < r < −0.259). Myo-inositol/tNAA correlated with myelopathy symptoms (r = −0.670), whereas CSC volume did not. Short-echo 1H-MRS provided neurochemical signatures of CSC impairment that reflected compression severity and clinical significance. Whereas volumetry only reflected clinically manifest myelopathy (DCM), MRS detected neurochemical changes already before the onset of myelopathy symptoms.
Links
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
NV18-04-00159, research and development projectName: Využití pokročilých magneticko-rezonančních technik k odhalení patofyziologie a zlepšení diagnostiky a praktického managementu degenerativní komprese krční míchy
Investor: Ministry of Health of the CR
90042, large research infrastructuresName: CESNET II
PrintDisplayed: 19/4/2024 21:57